McGurk JS et al. (2011), Postsynaptic TRPC1 function contributes to BDNF...

XB-ART-44015

J Neurosci 2011 Oct 12;3141:14754-62. doi: 10.1523/JNEUROSCI.3599-11.2011.

Show Gene links Show Anatomy links

Postsynaptic TRPC1 function contributes to BDNF-induced synaptic potentiation at the developing neuromuscular junction.

McGurk JS, Shim S, Kim JY, Wen Z, Song H, Ming GL.

???displayArticle.abstract???
Brain-derived neurotrophic factor (BDNF) induces synaptic potentiation at both neuromuscular junctions (NMJs) and synapses of the CNS through a Ca2+ -dependent pathway. The molecular mechanism underlying BDNF-induced synaptic potentiation, especially the regulation of Ca2+ dynamics, is not well understood. Using the Xenopus NMJ in culture as a model system, we show that pharmacological inhibition or morpholino-mediated knockdown of Xenopus TRPC1 (XTRPC1) significantly attenuated the BDNF-induced potentiation of the frequency of spontaneous synaptic responses at the NMJ. Functionally, XTRPC1 was required specifically in postsynaptic myocytes for BDNF-induced Ca2+ elevation and full synaptic potentiation at the NMJ, suggesting a previously underappreciated postsynaptic function of Ca2+ signaling in neurotrophin-induced synaptic plasticity, in addition to its well established role at presynaptic sites. Mechanistically, blockade of the p75 neurotrophin receptor abolished BDNF-induced postsynaptic Ca2+ elevation and restricted BDNF-induced synaptic potentiation, while knockdown of the TrkB receptor in postsynaptic myocytes had no effect. Our study suggests that BDNF-induced synaptic potentiation involves coordinated presynaptic and postsynaptic responses and identifies TRPC1 as a molecular mediator for postsynaptic Ca2+ elevation required for BDNF-induced synaptic plasticity.

???displayArticle.pubmedLink??? 21994391
???displayArticle.pmcLink??? PMC3213207
???displayArticle.link??? J Neurosci
???displayArticle.grants??? [+]

Species referenced: Xenopus
Genes referenced: bdnf ngfr nradd ntrk2 trpc1
???displayArticle.morpholinos??? ngfr MO1 ntrk2 MO2 trpc1 MO1

???attribute.lit??? ???displayArticles.show???

	Figure 1. XTRPC1 function is required for BDNF-induced synaptic potentiation at the developing NMJ in culture. A, Sample images of whole-mount in situ hybridization of XTRPC1 in stage 20â€“32 Xenopus embryos. Scale bar, 0.5 mm. B, Sample images of immunostaining of XTRPC1 (green) in neuron (N)â€“myocyte (M) cocultures from embryos coinjected with rhodamine dextran (red) and a specific morpholino against XTRPC1 (XTRPC1-Mo) or a control morpholino (Control-Mo). Scale bar, 10 Î¼m. C, Sample images of recording from a neuron (N) and myocyte (M) pair, both derived from XTRPC1-Mo-injected embryos, as indicated by the presence of fluorescent lineage tracer (green). Scale bar, 20 Î¼m. D, Sample electrophysiological recording traces from control-Mo (top) and XTPRC1-Mo pairs (bottom). Scale bars, 500 pA and 2 min. The addition of BDNF (50 ng/ml; final bath concentration) is indicated by the arrow. E, Fold changes in the frequency of spontaneous PSCs. Values represent mean Â± SEM; *p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). Inset: Mean frequency of spontaneous PSCs before and after BDNF application of individual cells plotted in Log2 scale. F, Cumulative distribution plots for the amplitude, 10â€“90% rise time, decay time, and interevent intervals (p < 0.01; Kolmogorovâ€“Smirnov test) of spontaneous PSCs of control-Mo and XTRPC1-Mo pairs before and after the BDNF application (50 ng/ml).
	Figure 2. Pharmacological inhibition of XTRPC1 function attenuates BDNF-induced synaptic potentiation at the developing NMJ. A, Sample electrophysiological recording traces with saline (top) or SKF treatment (bottom; 20 μM). The addition of BDNF (50 ng/ml) is indicated by the arrow. Scale bars, 500 pA and 2 min. B, Fold change in the frequency of spontaneous PSCs. Value represent mean ± SEM (control: n = 13; SKF96365 treatment: n = 14); *p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, Cumulative distribution plots for the amplitude, 10–90% rise time and decay time, and interevent intervals (p < 0.01; Kolmogorov–Smirnov Test) of spontaneous PSCs under different conditions.
	Figure 3. Knockdown of XTRPC1 presynaptically does not affect BDNF-induced synaptic potentiation at the developing NMJ. A, Sample images of recording of a neuron (N) and myocyte (M) pair with only the neuron derived from an XTRPC1-Mo-injected embryo as indicated by the tracer (green). Scale bar, 20 μm. B, Sample electrophysiological recording traces of a control-Mo neuron/wild-type myocyte pair (top) and a XTRPC1-Mo neuron/wild-type myocyte pair. The addition of BDNF (50 ng/ml) is indicated by the arrow. Scale bars, 500 pA and 2 min. C, Fold change in the frequency of spontaneous PSCs. Values represent mean ± SEM. There is no significant difference between control-Mo and XTRPC1-Mo group at each time point (p > 0.1; unpaired two-tailed Student's t test with Welch's correction). D, Cumulative distribution plots for the amplitude, 10–90% rise time, decay time, and interevent intervals (p > 0.05; Kolmogorov–Smirnov Test) of spontaneous PSCs under different conditions.
	Figure 4. Postsynaptic knockdown of XTRPC1 attenuates BDNF-induced potentiation at the NMJ. A, Sample images of recording of a neuron (N) and myocyte (M) pair in which only the myocyte was derived from an XTRPC1-Mo-injected embryo as indicated by the tracer (green). Scale bar: 20 μm. B, Sample electrophysiological recording traces of a control-Mo myocyte/wild-type neuron pair (top) and a XTRPC1-Mo myocyte/wild-type neuron pair. The addition of BDNF (50 ng/ml) is indicated by the arrow. Scale bars, 500 pA and 2 min. C, Fold change in the frequency of spontaneous PSCs. Values represent mean ± SEM; *p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). D, Cumulative distribution plots for the amplitude, 10–90% rise time, decay time, and interevent intervals (p < 0.01; Kolmogorov–Smirnov Test) of spontaneous PSCs under different conditions.
	Figure 5. BDNF induces Ca2+ elevation in myocytes. A, Sample confocal images of Fluo-4-containing myocyte (M)–neuron (N) pairs before and after BDNF stimulation (50 ng/ml). Note that BDNF-induced Ca2+ rise was blocked in the presence of SKF96365 (20 μM; bottom). Scale bar, 10 μm. Color scale bar indicates pixel value. B, Normalized F/F0 value of Ca2+ signal in myocytes within neuron–myocyte pairs. Values represent mean ± SEM (n = 7 for the control group; n = 8 for the SKF96365 treatment); p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, Summary of peak ΔF/F0 values of Ca2+ signal in myocytes under different conditions. Values represent mean ± SEM (n = 7 for the control group; n = 8 for the SKF96365 treatment; n = 8 for the SKF96365 treatment in isolated myocytes; n = 11 for XTRPC1-Mo myocytes; n = 5 for control and n = 4 for XTRPC1-Mo myocytes under voltage clamp); *p < 0.01 (unpaired two-tailed Student's t test with Welch's correction).
	Figure 6. Postsynaptic Ca2+ elevation in myocytes is required for BDNF-induced synaptic potentiation at the developing NMJs. A, B, Summary of the fold changes in spontaneous PSC frequency of wild-type neuron-myocyte pairs, where myocytes were loaded with Ca2+ chelator EGTA (5 mM) or BAPTA (5 mM),through the whole-cell recording pipette. The addition of BDNF (50 ng/ml; final bath concentration) is indicated by the arrow. Value represents mean ± SEM; *p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, Cumulative distribution plots for the amplitude, 10–90% rise time, decay time, and interevent intervals (p < 0.01; Kolmogorov–Smirnov Test) of spontaneous PSCs under different conditions.
	Figure 7. p75NTR function is required for BDNF-induced synaptic potentiation and postsynaptic Ca2+ elevation. A, TrkB function is required presynaptically, but not postsynaptically, for BDNF-induced potentiation. Shown is a summary of fold changes in spontaneous PSCs frequency with pairs of NMJs containing morpholino for XTRKB (XTRKB-Mo) in neurons and/or myocytes. The addition of BDNF (50 ng/ml; final bath concentration) is indicated by the arrow. Values represent mean ± SEM; *p < 0.01; p < 0.05 (Kruskal–Wallis ANOVA test and a Dunn's post-test). B, p75NTR is required postsynaptically for BDNF-induced synaptic potentiation. Shown is a summary of fold changes in spontaneous PSCs frequency after BDNF induction (50 ng/ml) in the presence of NGFR5 or the control antibody (5 μg/ml) or from p75NTR-Mo myocytes. Values represent mean ± SEM; p < 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, D, Cumulative distribution plots for the amplitude, 10–90% rise time, decay time, and interevent intervals (p < 0.01; Kolmogorov–Smirnov Test) of spontaneous PSCs under different conditions. E, F, p75NTR function is required for BDNF-induced Ca2+ response in myocytes. Shown in E are sample confocal images of Ca2+ responses of the myocytes in the presence of a control antibody (5 μg/ml; top) or NGFR5 (5 μg/ml; bottom). Scale bar, 10 μm. Shown in F is a summary of normalized F/F0 values in the myocytes. Values represent mean ± SEM (n = 9 for NGFR5; n = 7 for control IgG; n = 6 for p75NTR-Mo); p < 0.05 (unpaired two-tailed Student's t test with Welch's correction).
	trpc1 (transient receptor potential cation channel, subfamily C, member 1) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 25, lateral view, anterior left, dorsal up.

References [+] :

Amaral, TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation. 2007, Pubmed